Incidence of inflammatory bowel disease in Jakarta, Indonesia, 2021-24.

Conflict statement: CNB has received grants or contracts from Celltrion, Johnson & Johnson, and Takeda; consulting fees from Takeda; honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, Johnson & Johnson, Pfizer, Takeda, Fresenius-Kabi, Celltrion, and Medtronic; other financial or non-financial interests or educational grants from AbbVie, Amgen, Celltrion, Eli Lilly, Ferring, Fresenius-Kabi, Pendopharm, Organon, Sanofi, Johnson & Johnson, Pfizer, Takeda, and Boston Scientific; and has participated on Data Safety Monitoring Boards or Advisory Boards for AbbVie, Amgen, Celltrion, Eli Lilly, Ferring, Fresenius-Kabi, Pendopharm, Sanofi, Johnson & Johnson, Pfizer, and Takeda. GGK has received honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AbbVie, Janssen, Pfizer, Celltrion, and Takeda; grants or contracts from Ferring; and shares ownership of a patent of treatment of inflammatory disorders, autoimmune disease, and primary biliary cirrhosis (patent WO2019046959A1, PCT/CA2018/051098). MB-dA has received honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from MSD, AbbVie, Johnson & Johnson, Janssen, Kern Pharma, Takeda, Galapagos-Alpha Sigma, Pfizer, Sandoz, Fresenius, Avibax, Eli Lilly, Biocon, Ferring, Faes Farma, Dr. Falk Pharma, Chiesi, Adacyte, Tillots Pharma, Palobiofarma, OncoStellae, Medibiofarma, and SunRock; and support for attending meetings or travel from AbbVie, Johnson & Jonhson/Janssen, Takeda, and Eli Lilly. All other authors declare no competing interests. All authors contributed to reviewing the results, data analysis, manuscript revision, and shaping the discussion. JG and JJ designed and supervised the study and contributed to conceptualisation, data collection and curation, formal analysis, investigation, project administration, resources, and software. JJ contributed to visualisation. All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis and have seen and approved the manuscript. JG, CNB, GGK, MB-dA, J-FR, and GP contributed to writing the original draft, review and editing, and further methodology, sensitivity analysis, and interpretation.